PUBLISHER: The Business Research Company | PRODUCT CODE: 1946945
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946945
Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical tools used to open narrowed or blocked coronary arteries. They work by inserting a catheter with a small balloon at the tip into the artery and inflating it to widen the vessel and enhance blood flow, helping restore normal circulation to the heart through a minimally invasive procedure.
The primary types of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters include semi-compliant and non-compliant variants. Semi-compliant PTCA dilation catheters are engineered to expand under applied pressure while retaining a controlled degree of flexibility, enabling them to conform to vessel anatomy and provide effective dilation with reduced risk of vessel injury. These catheters are manufactured using materials such as polyurethane, nylon, and others and are used in applications across hospitals, medical research institutions, and others.
Tariffs have increased the cost of imported catheter materials such as polyurethane, nylon, and specialty polymers, raising production expenses for PTCA dilation catheter manufacturers. These impacts are most pronounced in high pressure non compliant and specialized semi compliant catheter segments, particularly in Asia-Pacific and Europe where many components are sourced globally. The resulting cost pressures have affected pricing for hospitals and medical research institutes, potentially slowing procurement cycles. However, tariffs are also encouraging regional sourcing of raw materials and local catheter assembly, improving supply chain resilience and supporting long term manufacturing stability.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report is one of a series of new reports from The Business Research Company that provides percutaneous transluminal coronary angioplasty (ptca) dilation catheters market statistics, including percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry global market size, regional shares, competitors with a percutaneous transluminal coronary angioplasty (ptca) dilation catheters market share, detailed percutaneous transluminal coronary angioplasty (ptca) dilation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry. This percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size has grown strongly in recent years. It will grow from $1.95 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising coronary artery disease prevalence, aging population, advancements in interventional cardiology, improved diagnostic imaging, hospital catheterization expansion.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growth in cardiovascular interventions, emerging market healthcare investments, innovation in catheter materials, increasing clinical expertise, adoption of precision cardiology. Major trends in the forecast period include increasing preference for minimally invasive procedures, growing use of high-pressure non-compliant catheters, demand for improved balloon material durability, expansion of cath lab infrastructure, focus on procedural success rate improvement.
The increase in cardiovascular diseases is increasingly supporting the expansion of the percutaneous transluminal coronary angioplasty dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle-related factors such as poor dietary habits, physical inactivity, elevated stress levels, and aging populations. Percutaneous transluminal coronary angioplasty dilation catheters are widely used to treat cardiovascular conditions by opening narrowed or blocked coronary arteries, thereby restoring adequate blood flow to the heart. For example, in June 2024, according to the American Heart Association, projections indicate that 45 million adults in the United States may have some form of cardiovascular disease by 2050, up from 28 million in 2020, with significant increases expected in hypertension and obesity rates. Consequently, the growing burden of cardiovascular diseases is reinforcing growth in the PTCA dilation catheters market.
Leading companies in the percutaneous transluminal coronary angioplasty dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and enable effective artery dilation. Twin-wall technology incorporates two concentric layers to improve catheter strength, flexibility, and durability. For example, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC PTCA dilation catheter with twin-wall technology in the US. The catheter offers high pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents and effective treatment of complex coronary lesions without over-dilation.
In June 2024, Boston Scientific Corporation, a US-based medical device manufacturing company, acquired Silk Road Medical Inc. for an undisclosed amount. This acquisition strengthens Boston Scientific's presence in the vascular and endovascular markets, particularly in the treatment of carotid artery disease. Silk Road Medical Inc. is a US-based manufacturer of medical equipment.
Major companies operating in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2025. The regions covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market consists of sales of balloon catheters, drug-eluting balloon catheters, scoring balloon catheters, and cutting balloon catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses percutaneous transluminal coronary angioplasty (ptca) dilation catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for percutaneous transluminal coronary angioplasty (ptca) dilation catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.